April 21, 2008 - The first patients were treated in a U.S. feasibility study using the Edwards Lifesciences SAPIEN transcatheter heart valve in addressing a congenital condition in which the valve between the right ventricle and the pulmonary artery is nonfunctional.

April 21, 2008 - Rapid cooling prior to reperfusion significantly reduced overall myocardial infarct size and protected the heart from other injury, according to a study by Cardium Therapeutics and its operating unit InnerCool Therapies, reported a study published online by BioMed Central (BMC) Cardiovascular Disorders (2008, 8:7, April 10, 2008).

April 16, 2008 - Boston Scientific Corp. will acquire CryoCor, Inc. and pay a cash purchase price of $1.35 per share of CryoCor, or approximately $17.6 million, as Boston Scientific pursues therapeutic solutions for atrial fibrillation (Afib).

April 21, 2008 - Angiotech Pharmaceuticals Inc. said last week it received 510(k) clearance from the FDA to market its 5-Fluorouracil (5-FU) coated central venous catheter (CVC).

The 5-FU CVC is the first drug-eluting medical device to be researched and developed completely in-house by Angiotech's research and development department. The company said it will be stepping stone for development of other implantable devices that utilize the same proprietary anti-infective technology.

April 18, 2008 - Boston Scientific Corpo. has received approval for the sale of its TAXUS Liberte paclitaxel-eluting coronary stent system in Canada, which it plans to launch the product immediately in Canada.

The Company reported that Health Canada's Therapeutic Products Directorate (TPD), the authority that regulates pharmaceutical drugs and medical devices, has approved its use.

ViTALConnect software is a Web-enabled medical tool that allows physicians to use PCs or notebook computers to access interactive 2D, 3D and 4D advanced visualization. ViTALConnect software offers users access that is critical in today’s hospital environment. This solution enables users to review studies and perform advanced analysis from any where at any time.

April 17, 2008 - Medtronic Inc. received clearance from the FDA for use of the Talent Abdominal Stent Graft on the CoilTrac Delivery System, a medical device that expands patient access to a minimally-invasive treatment option for abdominal aortic aneurysms.

Medtronic's Talent Abdominal Stent Graft is FDA cleared for use on the CoilTrac Delivery System, a medical device that expands patient access to a minimally-invasive treatment option for n Memorial Hospital's Endovascular Program in Baltimore, was the principal investigator for the study.

April 16, 2008 - In a recent study conducted by Lund University Hospital, Sweden, the effect of induced hypothermia prior to reperfusion was shown to significantly reduce overall myocardial infarct size (a measure of tissue damage in the heart) and protected the heart from other injury.

Smiths Medical offers the Level 1 ConductiTherm Warming System with built-in pressure relief designed for positioning under the patient.

The warming system comprises a silent, IV pole mountable control unit and a mattress positioned under the patient, and is capable of warming patients without restricting access.

March 2008

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now